Sign in

CIK 0001745999 · Large accelerated filer

Beam Therapeutics Inc.

Sign in to watch
Ticker
BEAM
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
857-327-8775
Business address
26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
Former names
Beam Therapeutics Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,193,310
in 2 filings, $1.2M under 10b5-1 plans

Net −$1,193,310. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2022-07-28 Evans John M. CEO Sale −173 $68.49 $12K 1,088,520
2022-07-28 Evans John M. CEO Sale −6,953 $64.88 $451K 136,047
2022-07-28 Evans John M. CEO Sale −10,599 $65.92 $699K 125,448
2022-07-28 Evans John M. CEO Sale −201 $66.61 $13K 125,247
2022-07-28 Evans John M. CEO Sale −2,247 $67.82 $152K 123,000
2022-04-28 Evans John M. CEO Option exercise +12,246 $7.22 $88K 1,101,316
2022-04-28 Evans John M. CEO Option exercise +47,204 $1.03 $49K 1,148,520
2022-04-28 Evans John M. CEO Sale −3,900 $36.59 $143K 1,144,620
2022-04-28 Evans John M. CEO Sale −13,655 $37.48 $512K 1,130,965
2022-04-28 Evans John M. CEO Sale −6,842 $38.32 $262K 1,124,123
2022-04-28 Evans John M. CEO Sale −4,503 $39.49 $178K 1,119,620
2022-04-28 Evans John M. CEO Sale −1,100 $40.73 $45K 1,118,520
2022-04-28 Evans John M. CEO Sale −6,450 $36.98 $239K 156,550
2022-04-28 Evans John M. CEO Sale −7,745 $37.84 $293K 148,805
2022-04-28 Evans John M. CEO Sale −3,100 $38.75 $120K 145,705
2022-04-28 Evans John M. CEO Sale −2,348 $39.73 $93K 143,357
2022-04-28 Evans John M. CEO Sale −357 $40.88 $15K 143,000
2022-04-28 Evans John M. CEO Option exercise · Stock Option (Right to Buy) −12,246 210,754
2022-04-28 Evans John M. CEO Option exercise · Stock Option (Right to Buy) −47,204 237,141
2022-04-13 FMR LLC 10% owner Sale −663 $50.75 $34K 0

Page 16 of 32 · 630 trades